Hematological adverse effects in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
- Citation:
- Kassem, L., K. S. Shohdy, S. Lasheen, O. Abdel-Rahman, and T. Bachelot,
"Hematological adverse effects in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis",
Breast Cancer, vol. 25, issue 1: Springer Japan, pp. 17 - 27, 2018/01//.
Abstract:
n/a
Notes:
n/a